miRoncol Health
miRoncol leadership

Gilles Erb, PhD

Medical & Scientific Director

Gilles brings the diagnostic-development experience required to connect broad molecular discovery with a test that can be validated, operated and understood in clinical settings.

FORMER ROCHE (FMI) SCIENTIFIC DIRECTORDIAGNOSTICS
Gilles Erb, PhD
Experience behind the platform

Why Gilles’s experience matters.

Gilles Erb, PhD, has more than 20 years of global industry experience in oncology diagnostics and clinical validation. He previously served as Global Scientific Director for Integrated Molecular Medicine at Roche and Foundation Medicine.

His work sits at the intersection of research, diagnostic development and clinical use. At miRoncol, he contributes medical and scientific leadership as the company advances from published microRNA models toward validated laboratory applications.

For investors and partners, his experience adds an important translation layer: the analytical platform must be matched by reproducible measurement, quality systems and an application-specific validation path.

Related company milestones.

World’s first published miRNA MCED model

Multi-cancer proof-of-concept milestone

One multidisciplinary company

Five leadership perspectives. One platform direction.

Company building, clinical oncology, diagnostic translation, bioinformatics and marketing work together to move miRoncol from research to responsible applications.

Explore miRoncol